CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy. - Wikidata - awgldk - TriplyDB

CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.

CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.

http://www.wikidata.org/entity/Q35106277

about

Metabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular Dystrophy The clinical relevance of outcomes used in late-onset Pompe disease: can we do better?Nutraceuticals and Their Potential to Treat Duchenne Muscular Dystrophy: Separating the Credible from the Conjecture What can Duchenne Connect teach us about treating Duchenne muscular dystrophy?Online self-report data for duchenne muscular dystrophy confirms natural history and can be used to assess for therapeutic benefits Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.Motor and cognitive assessment of infants and young boys with Duchenne Muscular Dystrophy: results from the Muscular Dystrophy Association DMD Clinical Research Network.A critical review of functional assessment tools for upper limbs in Duchenne muscular dystrophy.Exercise in neuromuscular disease.ROS and RNS signaling in skeletal muscle: critical signals and therapeutic targets.What has the mdx mouse model of Duchenne muscular dystrophy contributed to our understanding of this disease?Drug Discovery of Therapies for Duchenne Muscular Dystrophy.Nutrition Considerations in Duchenne Muscular Dystrophy.Pharmacological therapeutics targeting the secondary defects and downstream pathology of Duchenne muscular dystrophy Improvement of endurance of DMD animal model using natural polyphenols.Skeletal muscle mitochondrial bioenergetics and associations with myostatin genotypes in the Thoroughbred horse.Dystrophin-deficient muscular dystrophy in a Norfolk terrier.

P2860

Q26772002-8B2760AC-996C-4614-86B5-3EFFFAC064BE Q27021472-E0855450-1CFE-461A-93B4-7CC9B7536F6F Q28072269-F716DA6C-7C83-44B0-8A9F-0C16D69A345E Q28080926-50936DAF-C5C2-4A4E-A536-149ECB8D8FB9 Q28544012-898A6743-4F30-46C3-B25B-949AF72893A1 Q34685307-0E3D3C42-AF33-4854-988F-E0C448512D5F Q37095860-056A3548-81EB-4B5F-9E62-9859498F96EF Q38019990-4A7AE5C2-C43F-474C-AD2C-17518FDED8B5 Q38108541-024F3B21-E9D1-4894-AE0C-D2E0FCE7EC56 Q38217375-51CFF3A8-06A9-4439-ABC4-3B59F6C8CC95 Q38351283-9B3638FE-EBCA-448C-A140-ED11A7FF36F1 Q38480698-F8832307-AA8E-4974-99BA-0B7C2C7692CE Q38482328-27B475BF-CC2C-49C4-9432-4D952FDC7D0C Q39410461-BA9FC5E5-D87E-4CD4-AAA4-A38DAC588999 Q41091176-761E448C-F0E1-49EC-9CF4-D9EC6B5537E2 Q47137470-399A0D04-C4FE-4F82-A518-73254798901D Q54312658-1577CCF3-4602-4374-AC87-A4A9B90A9B0F

P2860

CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.

http://www.wikidata.org/entity/Q35106277

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.

@ast

CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.

@en

type

label

CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.

@ast

CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.

@en

prefLabel

CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.

@ast

CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy.

@en

P1433

Q35106277-2DAAFDF7-21A0-4CDD-8FE7-924379F96451

P1476

Q35106277-7A87EF09-BEAD-4207-A0E9-8CFC9C91F080

P2093

Q35106277-1FD8C81C-673A-4907-98DC-977DDD6396C8

Q35106277-4325D00D-4275-4AD5-B6E5-C4A8CECDCF2B

Q35106277-48249442-A47E-49F9-94B6-66941A57FAA4

Q35106277-56717869-5D41-4905-B5E2-ACC3902B0A21

Q35106277-68F74FF1-0F90-4F82-A1E9-80A7D4BCA10B

Q35106277-6C0725EE-96E5-4776-816B-D2CD04274380

Q35106277-75322EB8-B462-4098-B881-B3AE608DCE7A

Q35106277-7AB11338-D0DF-4F16-BE11-AFE0DA737861

Q35106277-8EBDD509-7E29-4A3A-B8BC-BDDF00BE4935

Q35106277-93FE1726-E6D0-4396-A095-A5731B9720FF

P2860

Q35106277-07E32EE3-D7D3-4955-9C2E-BB7D8266183E

Q35106277-08C29A80-6037-4AD3-92D7-B99B97ED7BFC

Q35106277-1A2A178B-9343-4C97-A954-B42CCF6014B6

Q35106277-3A67908A-482E-4977-8CF7-49ED85B55415

Q35106277-435E7653-9F19-4485-909C-2E6CEC616607

Q35106277-67DCF5DB-DA9A-4745-B542-BD116A5BA2A4

Q35106277-6C58AEF1-317F-4E85-A6EA-B53380A83E94

Q35106277-6F524FAE-8768-40EF-8EED-E5363608E37C

Q35106277-72039CDE-0A73-47D8-8633-5E70F0F5FF5B

Q35106277-A76A3F27-3541-463A-AE16-5179A3DAE520

P304

Q35106277-5CD49A70-7E26-4984-9611-C99A78E5D618

P31

Q35106277-398AE680-0C1E-4339-954C-FFB5FAA5F734

P356

Q35106277-6349BDEE-540B-47A2-A29F-B3D021B5C63D

P433

Q35106277-E3C20AF3-B469-412D-B77E-FC585C196E1C

P478

Q35106277-F772A3C9-0ACC-48BE-9128-6DBBE9BEF508

P50

Q35106277-171FAE7C-4894-44A9-8596-1381766A4627

P577

Q35106277-0927D2E6-E469-4472-9579-E5CB4668BBDC

P5875

Q35106277-07B67200-D575-46F9-982F-F973E8B6AA72

P698

Q35106277-450C82D2-1511-4BED-87EB-7FFE04B8BA76

P921

Q35106277-38EA2BCA-C825-4FE8-9879-EE6A266829E2

P932

Q35106277-EB2F0EDD-8E27-4330-9EAF-3D3C85B4DAB4

P356

P1433

Muscle and Nerve

P1476

CINRG pilot trial of coenzyme Q10 in steroid-treated Duchenne muscular dystrophy

@en

P2093

Alan Pestronk

http://www.w3.org/2001/XMLSchema#string

Anne M Connolly

http://www.w3.org/2001/XMLSchema#string

Carolina Tesi Rocha

http://www.w3.org/2001/XMLSchema#string

Christopher F Spurney

http://www.w3.org/2001/XMLSchema#string

Cooperative International Neuromuscular Research Group Investigators

http://www.w3.org/2001/XMLSchema#string

Diana M Escolar

http://www.w3.org/2001/XMLSchema#string

Erik Henricson

http://www.w3.org/2001/XMLSchema#string

Fengming Hu

http://www.w3.org/2001/XMLSchema#string

Gerard R Martin

http://www.w3.org/2001/XMLSchema#string

Jill Mayhew

http://www.w3.org/2001/XMLSchema#string

P2860

Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property.

Assay of coenzyme Q10 in plasma by a single dilution step.

Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Biochemical rationale and the cardiac response of patients with muscle disease to therapy with coenzyme Q10.

Clinical investigation of Duchenne muscular dystrophy. A methodology for therapeutic trials based on natural history controls.

Sensitivity analysis for nonrandom dropout: a local influence approach.

Coenzyme Q10: absorption, antioxidative properties, determinants, and plasma levels.

The use of score tests for inference on variance components.

CINRG randomized controlled trial of creatine and glutamine in Duchenne muscular dystrophy.

Steroid therapy and cardiac function in Duchenne muscular dystrophy.

P304

174-178

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/MUS.22047

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

44

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-06-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51243578

http://www.w3.org/2001/XMLSchema#string

P698

21698649

http://www.w3.org/2001/XMLSchema#string

P921

P932

3136634

http://www.w3.org/2001/XMLSchema#string